Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases
NCT00538551 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 350
Last updated 2011-12-13
Summary
Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases
Conditions
- Hodgkin Disease
- Lymphoma, Non-Hodgkin
Interventions
- OTHER
-
Database
Database
Sponsors & Collaborators
-
King Faisal Specialist Hospital & Research Center
lead OTHER
Principal Investigators
-
Syed Akhtar, MD · KFSH & RC
Eligibility
- Min Age
- 14 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2012-07-31
- Completion
- 2015-07-31
Countries
- Saudi Arabia
Study Locations
More Related Trials
-
Intercontinental Cooperative Non-Hodgkin T-cell Lymphoma Prospective Registry Study
NCT02691351 ·Status: COMPLETED
-
Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy
NCT03535948 ·Status: UNKNOWN
-
Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors
NCT00001301 ·Status: COMPLETED
-
Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study
NCT04982471 ·Status: TERMINATED
-
Study of Lymphoma in Asia
NCT01584141 ·Status: COMPLETED
-
A Registry for People With T-cell Lymphoma
NCT05978141 ·Status: RECRUITING
-
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
NCT01110733 ·Status: COMPLETED
-
PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGE
NCT07313943 ·Status: RECRUITING
-
Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT05318391 ·Status: COMPLETED
-
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
NCT05705531 ·Status: RECRUITING
-
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma
NCT00900250 ·Status: COMPLETED
-
Bergamo Lymphoid Cancer Registry
NCT03131531 ·Status: RECRUITING
-
Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma
NCT06813573 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00147953 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Study of Lymphoproliferative Diseases
NCT01704742 ·Status: WITHDRAWN
-
The Clinical Implications of Immune Checkpoint Pathways in PCNSL
NCT04158128 ·Status: COMPLETED
-
Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission
NCT04298619 ·Status: COMPLETED
-
Frequency of Pulmonary Toxicity in Patients Treated for Hodgkin Lymphoma
NCT06761599 ·Status: ACTIVE_NOT_RECRUITING
-
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
NCT05886036 ·Status: RECRUITING ·Phase: PHASE2
-
China Lymphoma Patient Registry Study
NCT03313271 ·Status: RECRUITING
-
A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
NCT05907447 ·Status: UNKNOWN
-
Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
NCT00112931 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanism of Resistance to GNC-038 in Relapsed and Refractory Diffuse Large B-cell Lymphoma
NCT05189782 ·Status: UNKNOWN
-
Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma
NCT00169169 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of Patient and Lesion Specific Prognostic Factors for Standard Radioimmunotherapy
NCT01151358 ·Status: UNKNOWN